3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Mouth Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Tongue Neoplasms
1
Solid Tumor
1
Skin Lesion
1
Renal Colic
1
Rectal Neoplasms
1
Pregnancy, Ectopic
1
Postoperative Complications
1
Pneumonia
1
Pleural Effusion
1
Phlebitis
1
Pancreatic Neoplasms
1
Lymphoma, Primary Effusion
1
Lymphoma, B-Cell
1
Lymphoma, AIDS-Related
1
Liver Neoplasms
1
Kidney Neoplasms
1
Gastrointestinal Neoplasms
1
Cysts
1
Cholecystitis
1
Brain Neoplasms
1
Arachnodactyly
1
Abortion, Spontaneous
1
Interventions
pembrolizumab
137
Nivolumab
116
Ipilimumab
68
Cyclophosphamide
33
Specimen Handling
31
Magnetic Resonance Spectroscopy
28
trametinib
23
binimetinib
22
fludarabine
21
Interleukin-2
20
dabrafenib
19
relatlimab
17
encorafenib
17
Biopsy
17
CTLA-4 Antigen
16
cemiplimab
15
atezolizumab
15
aldesleukin
15
Radiosurgery
15
fludarabine phosphate
14
Opdualag
14
Radiotherapy
11
lenvatinib
10
Blood Specimen Collection
10
lifileucel
9
Paclitaxel
8
Cisplatin
8
Bevacizumab
8
spartalizumab
7
cobimetinib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Ultrasonography
×
1 year
×
Clear all
No trials found.